Searched for
FORMULATIONS INDIA PVT LTD.
These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Crystal Crop Protection buys FMC India businessFMC Corporation is selling its India business to Crystal Crop Protection for $252 million. This deal includes commercial crop protection ac...
- Meet the winners of the ET MSME Awards 2025From nanobubble tech and agro-exports to e-waste recycling and specialty chemicals, the best Indian MSMEs across 20 categories redefined wh...
- Sanofi gets nod for new polio vaccine in IndiaTo ensure that there is no interruption to the availability of IPV vaccines, the French firm has already obtained approvals for IMOVAX-Poli...
- Delhi excise 'scam': Court grants bail to two men accused of transferring kickbacks for AAP's poll expenseThe CBI had opposed the bail application, claiming that even though the accused were not a party to the formulation of excise policy or the...
- CCI clears deal involving Sekhmet Pharmaventures, Optimus DrugsIn a tweet on Friday, the watchdog said it has approved acquisition of majority shareholding in Optimus Drugs by Sekhmet Pharmaventures as ...
- ExxonMobil partners Think Gas to market range of CNG lubricantsVipin Rana, CEO, ExxonMobil Lubricants Pvt. Ltd. said “There is a growing preference for CNG vehicles in India and Think Gas is creating in...
- Abbott introduces single-dose formulation of carbetocin in IndiaPPH, if left untreated, can result in complications like anaemia in the postpartum period or aggravate mental health problems including pos...
- CSIR-IICT, Bengaluru pharma firm join hands to manufacture anti-COVID drug 2-DGThe CSIR-Indian Institute of Chemical Technology (IICT) here and Bengaluru-based Anthem Biosciences Pvt Ltd have entered into an agreement ...
- Sun Pharma, Ferring Pharmaceuticals ink pact to introduce obstetric drug in IndiaAs per the agreement, Sun Pharma is granted rights for co-marketing of the drug in India in the private market under the brand name Caritec...
- PolyOne Corp set to buy engineering plastic maker Formulated PolymersEstablished in 1993, Formulated Polymers Ltd designs and manufactures a range of thermoplastic compounds, specializes in Engineering Plasti...
- Lupin partners Eli Lilly to market diabetes drug 'Eglucent'According to the agreement, Lupin will market and sell Eglucent through its own specialty field force while Lilly will be responsible for m...
- Blockbuster Hepatitis C drug now under price controlDrug-pricing watchdog National Pharmaceutical Pricing Authority (NPPA) has brought under price control revolutionary drug 'Sofosbuvir' pres...
- Authorities order to end unauthorised web-based taxi servicesThe communication has been sent after the receipt of a letter from the Ministry of Home Affairs, directing states to stop all such transpor...
- FIPB to take up 32 foreign investment proposals on TuesdayFDI in India increased by about 16 per cent year-on-year to $ 1.44 billion in June, which is the lowest figure during the calender year.
- Money inflow intact, 4 pharma FDI plans okayedThe Foreign Investment Promotion Board (FIPB) examines FDI proposals that are on the approval route, but in the case of pharmaceutical sect...
- Aventis to acquire Universal Medicare's nutraceutical bizAventis Pharma said it will acquire the branded nutraceutical formulations business of Mumbai-based Universal Medicare Pvt Ltd.
- Maran clears 40 FDI proposals for Rs 76crUnion commerce and industry minister Murasoli Maran has cleared 40 foreign direct investment proposals worth Rs 76 crore.
- Pharma cos concerned over draft drug policyTHE Cabinet is supposed to clear a new, more liberal drug price control policy when it meets on February 5. But there are fears that the dr...
Load More
